-
New Safe and Environmentally Friendly Method for Determining the Formol Number Developed
In collaboration with BioSystems SA, Spain and other labs, Tentamus chelab has developed a new, safe, and environmentally friendly method for determining the formol number. Tentamus chelab is now replacing the older method (IFU 30) with this innovative approach, which uses toxic formaldehyde, marking an important step forward in sustainable laboratory analysis. The IFU has also adopted this approach in Recommendation R24. The conventional formol number determination method poses potential health and environmental risks and often requires manual procedures that are both time- and labor-intensive. The newly developed method eliminates these drawbacks entirely. It is based on the quantification of primary amine nitrogen (PAN) using the o-phthaldialdehyde (OPA) enzymatic method…
-
Techni’sens photo app rebuilds confidence between consumers and cosmetics brands
Brands are increasingly challenged to demonstrate product effectiveness in ways that consumers trust. Traditional consumer research (surveys, lab tests or in-person evaluations) can be slow, costly and might miss subtle real-world effects. To address this, TECHNI’SENS has developed a new photo app that allows participants to take standardized photos at home that are immediately ready for analysis, giving research teams enhanced precision in observing and measuring product performance. The cosmetics sector relies on nuanced visual cues, such as skincare improvement or makeup wear, to evaluate product performance. TECHNI’SENS photo app guides participants to take consistent photos, which are analyzed by AI algorithms to evaluate specific indicators such as coverage (surface…
-
Tentamus Group appoints Mandy Deimel as Managing Director Pharma DACH
The Tentamus Group is pleased to announce that Mandy Deimel will join the company on November 1st, 2025, as Managing Director Pharma DACH. In this role, Mandy will lead VelaLabs, taking over from Peder Andersen, who has served as Interim Managing Director since June 2025. She will also assume the position of Managing Director of Tentamus Pharma und Med Deutschland GmbH. Mandy Deimel brings extensive experience in the life sciences sector. She has held multiple Managing Director roles with full P&L responsibility across international organizations in pharma, diagnostics, biotech, and medical devices. Her expertise spans GxP compliance (GMP, GLP, GCLP), regulatory affairs, and pharmaceutical quality systems, and she has successfully…
-
Verantwortung trifft Innovation: Ralf Sibbing über Ethik, Sicherheit und die Kraft unabhängiger Beratung in der Gesundheitsbranche!
Die pharmazeutische Industrie und die Medizinprodukteindustrie gehören zu den am strengsten regulierten Bereichen der Gesundheitswirtschaft. In der neuen Folge des WHYIT-Campus Campod-Podcasts sprechen Ralf Sibbing, Geschäftsführer der TentaConsult Pharma & Med GmbH, und Burkhart Breuer, Geschäftsführer des WhyitCampus in Münster, darüber, wie Ethik, Sicherheit und Innovation zusammenwirken, um Vertrauen zu schaffen und Qualität dauerhaft zu sichern. Im Mittelpunkt des Gesprächs steht die Frage, warum Regulierung weit mehr bedeutet als reine Formalität und wie sie zur ethischen Grundlage verantwortungsvoller Produktentwicklung wird. Ralf Sibbing beschreibt, dass Ethik in jedem Schritt des Entwicklungsprozesses verankert sein muss, von der ersten Idee bis zur Markteinführung eines Produkts. Nur wenn wissenschaftliche Sorgfalt mit moralischer Integrität verbunden…
-
New Method: Typing of Salmonella Strains via RT-PCR
Salmonellosis is an intestinal infection caused by Salmonella, transmitted through contaminated food or water, as well as contact with infected animals. Salmonella can be found in raw or undercooked meat, raw eggs, unpasteurized milk, fresh cheeses made from unpasteurized milk, and fruits and vegetables irrigated with contaminated water. Approximately 2,500 Salmonella serotypes have been identified, but the strains most frequently responsible for infections are Salmonella enteritidis and Salmonella typhimurium, commonly referred to as the major Salmonella serovars. Interest in typing Salmonella isolates continues to grow. In Italy, the new National Plan for the Control of Salmonellosis in Poultry 2025–2027 (PNCS) includes full typing—of both major and minor serovars—of Salmonella strains…
-
Roy Sperling appointed as second Managing Director of bilacon as of October 1, 2025
bilacon GmbH is pleased to announce that Mr. Roy Sperling will join Mr. Frank Barsch in leading the company as Managing Director, effective October 1, 2025. Roy Sperling has been closely connected with bilacon for many years. He first joined the company in 2010 as a working student in Berlin and has since taken on numerous positions of responsibility – including roles as scientist, department head, and laboratory manager. From 2018, he headed the instrumental analytics department in Berlin before successfully establishing and managing the new laboratory in Rotterdam in 2019. In June 2024, he was granted power of attorney and assumed responsibility for managing the Berlin and Rotterdam sites.…
-
Roy Sperling wird zum 1. Oktober 2025 als zweiter Geschäftsführer der bilacon ernannt
Die bilacon GmbH freut sich, bekanntzugeben, dass Herr Roy Sperling ab dem 1. Oktober 2025 gemeinsam mit Herrn Frank Barsch die Geschäftsführung des Unternehmens übernehmen wird. Roy Sperling ist seit vielen Jahren fest mit der bilacon verbunden. Bereits 2010 begann er als Werkstudent in Berlin und übernahm im Laufe der Jahre zahlreiche verantwortungsvolle Positionen – unter anderem als Wissenschaftler, Bereichsleiter und Laborleiter. Seit 2018 leitete er die Abteilung instrumentelle Analytik in Berlin, bevor er 2019 erfolgreich den Aufbau des neuen Labors in Rotterdam verantwortete und dieses leitete. Im Juni 2024 wurde ihm die Prokura erteilt, verbunden mit der Standortleitung für Berlin und Rotterdam. Mit seiner Ernennung zum Geschäftsführer setzt Roy…
-
When QM works, it becomes a supporting structure. TentaConsult puts regulatory thinking into practice
Quality management should not be administrative, but should relieve the burden – create clarity, provide security and function in day-to-day operations. This is exactly where TentaConsult comes in: The consulting team with offices in Münster and Martinsried supports players from the medical technology, pharmaceutical, cosmetics and food supplements sectors in not only fulfilling complex regulatory requirements but also translating them into lively and sustainable structures. TentaConsult stands for quality management that is not just created on paper but grows within the company and is practised on a daily basis. Each system is developed in such a way that it keeps pace with daily requirements. It does not stop at formal…
-
Wenn QM funktioniert, wird es zur tragenden Struktur. TentaConsult bringt regulatorisches Denken in die Praxis
Qualitätsmanagement soll nicht verwalten, sondern entlasten – Klarheit schaffen, Sicherheit geben und im Betriebsalltag funktionieren. Genau dort setzt TentaConsult an: Das Beratungsteam mit Standorten in Münster und Martinsried unterstützt Akteure aus Medizintechnik, Pharma, Kosmetik und Nahrungsergänzungsmitteln dabei, komplexe regulatorische Anforderungen nicht nur zu erfüllen, sondern sie in lebendige und tragfähige Strukturen zu übersetzen. TentaConsult steht für Qualitätsmanagement, das nicht nur auf dem Papier entsteht, sondern im Unternehmen wächst und täglich gelebt wird. Jedes System wird so entwickelt, dass es mit den täglichen Anforderungen Schritt hält. Es bleibt nicht bei formalen Vorgaben, sondern schafft Raum für echte Prozessklarheit, eindeutige Zuständigkeiten und nachvollziehbare Dokumentation. „Wir entwickeln keine Systeme, die man für eine…
-
BDC Laboratories Partners with Dilawri Cardiovascular Institute to Improve Heart Device Performance and Patient Outcomes
BDC Laboratories, a Tentamus Company and recognized leader in cardiovascular device testing solutions, has announced a strategic partnership with the newly established Dilawri Cardiovascular Institute (DCI). This collaboration is set to accelerate the development, validation, and clinical relevance of next-generation cardiovascular medical devices. DCI comprises 16 core centers uniting research with every aspect of cardiac practice. The partnership aligns with the launch of DCI’s Center for Cardiovascular Translational Science, a hub dedicated to advancing device testing and simulation in collaboration with academic, clinical, and industry partners—from start-ups to established manufacturers—with a strong emphasis on transcatheter heart valve technologies. By integrating BDC’s regulatory-grade bench testing capabilities with DCI’s clinical expertise, the…
